fda warning letters compounded tirzepatide 2024 2025 issues 30 to online GLP-1 compounders FDA Warning Letter Breakdown: Sterility

Studies have consistently demonstrated the peptide's ability to accelerate healing of tendon injuries, with research showing enhanced recovery from Achilles tendon transection, improved tendon-to-bone healing, and faster restoration of biomechanical properties in damaged tendons

Proc Natl Acad Sci U S A 104: 94579462

In addition to targeting GLP-1 receptors, tirzepatide also activates GIP receptors, which may help influence appetite control, insulin response, and metabolic regulation more broadly

When we formulate, we look for wild-crafted and organic sources wherever possible

GLP-1 Receptor Agonists (GLP-1 RAs)